Technical Analysis for STIM - Neuronetics, Inc.

Grade Last Price % Change Price Change
grade F 17.99 3.21% 0.56
STIM closed up 3.21 percent on Friday, February 15, 2019, on 75 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Earnings due: Feb 19

1 Watcher
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Up Up
See historical STIM trend table...

Date Alert Name Type % Chg
Feb 15 Crossed Above 50 DMA Bullish 0.00%
Feb 15 Weak + Overbought Other 0.00%
Feb 15 Wide Bands Range Expansion 0.00%
Feb 15 Overbought Stochastic Strength 0.00%
Feb 14 Stochastic Sell Signal Bearish 3.21%
Feb 14 Weak + Overbought Other 3.21%
Feb 14 Outside Day Range Expansion 3.21%
Feb 14 Wide Bands Range Expansion 3.21%
Feb 14 Overbought Stochastic Strength 3.21%
Feb 13 MACD Bullish Centerline Cross Bullish 3.09%

Older signals for STIM ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators
Basic chart:
Profile
  • Earnings date: 2019-02-19
Neuronetics Inc is a commercial stage medical technology company. It is focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.
Health Psychiatry Neurotechnology Corcept Therapeutics Treatment Of Depression
Is STIM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Feb 15 Neuronetics, Inc. Announces Appointment of Dr. Cheryl R. Blanchard to its Board of Directors
Jan 24 The Daily Biotech Pulse: Partial Clinical Hold On Advaxis Cervical Cancer Drug, Ohr's Reverse Split, Ironwood Starts Phase 1 Trial
Jan 23 The Daily Biotech Pulse: PTC Therapeutics, Select Biosciences Offering, Unity Biotech Expands Early-Stage Osteoporosis Drug Study
Jan 17 The Daily Biotech Pulse: FDA Panel Backs Amgen's Hypertension Drug, Adamis Allergy Drug Launched In US
Jan 16 The Daily Biotech Pulse: Revance Common Stock Offering, Adcom Catalyst For Amgen
Jan 7 Neuronetics announces preliminary Q4 and FY2018 revenue
Jan 7 Neuronetics Announces Preliminary Fourth Quarter and Full Year Revenue
Dec 20 Neuronetics Could Feel The Heat When Lock-Up Expires
Dec 20 Who Has Been Buying Neuronetics, Inc. (NASDAQ:STIM) Shares?
Nov 27 At FDA, a new goal, then a push for speedy device reviews
See more STIM news...
Indicators
Indicator Value
52 Week High 39.39
52 Week Low 13.26
Average Volume 124,166
200-Day Moving Average 0.0
50-Day Moving Average 17.664
20-Day Moving Average 16.426
10-Day Moving Average 17.361
Average True Range 0.8564
ADX 14.09
+DI 23.5719
-DI 20.6748
Chandelier Exit (Long, 3 ATRs ) 15.8808
Chandelier Exit (Short, 3 ATRs ) 15.8292
Upper Bollinger Band 19.1552
Lower Bollinger Band 13.6968
Percent B (%b) 0.79
BandWidth 33.230245
MACD Line 0.1302
MACD Signal Line -0.1183
MACD Histogram 0.2485
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.40
Resistance 3 (R3) 19.40 18.92 19.17
Resistance 2 (R2) 18.92 18.56 18.93 19.09
Resistance 1 (R1) 18.46 18.34 18.69 18.46 19.01
Pivot Point 17.98 17.98 18.10 17.99 17.98
Support 1 (S1) 17.52 17.62 17.75 17.52 16.97
Support 2 (S2) 17.04 17.40 17.05 16.89
Support 3 (S3) 16.58 17.04 16.82
Support 4 (S4) 16.58